Nicheloom visits: 62,482 all-time · 8,415 in the last 7 days

The opportunity tracker for new startups.

Today: 2,085 launches · Niche of the day: browser-based utility tools · See what launched today →

Juno

AI health companion for chronic illness

Get picks like this daily. Today's launch numbers, the top launches, AI and tech news, and a daily opportunity pick, straight to your inbox.

Want to reach these readers? Sponsor an issue.

Juno helps people living with chronic illness reduce symptoms, spot patterns, and shorten the path to diagnosis. Built on our Oxford research and 1,000+ patient interviews.

PH · launched Jun 11, 2026 · 153 upvotes (top 99%) · 0 views

Niche: personal health and medication tracking apps · 250 launches, 23 in the last 7 days ▼ -12% · Explore this niche →

Category and tags

  • Healthcare
  • Agent / copilot
  • B2C
  • AI-native
  • Commercial product
  • Health & Fitness
  • Artificial Intelligence
  • Health

Visit website ↗ Source listing ↗

Could you build this?

No Creating a chronic illness diagnostic and management companion requires clinical medical validation, regulatory compliance (HIPAA/FDA SaMD considerations), and academic clinical research datasets.

What it would actually take: Beyond a symptom logging app, Juno relies on clinical ontologies (SNOMED, ICD-10), peer-reviewed chronic disease progression modeling, and patient interview datasets. It requires validation trials with medical professionals, stringent health data compliance, and specialized algorithmic safeguards against AI medical hallucinations.

Competitors

Other products that read as similar to this one : 128 launches clear the similarity bar, closest 8 shown.

Attention rank: #129 of 129 (itself plus its competitors, highest first, normalized so YC and Product Hunt are compared fairly).

Launched 222 days after the earliest competitor.

The niche, labels, vibe code rating and competitor comparison on this page are analysis by Nicheloom. If you use them, please credit nicheloom.com. How you may use our data.